Semaglutide For Weight Loss In Non Diabetics Dosage
Semaglutide, initially approved for the treatment of type 2 diabetes, has recently gained attention for its efficacy in weight management for non-diabetic individuals. Marketed under brand names such as Ozempic, Wegovy, and Rybelsus, semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of the GLP-1 hormone, which plays a significant role in regulating appetite and food intake. This article explores the use of semaglutide for weight loss in non-diabetic patients, including recommended dosages, mechanism of action, efficacy, and potential side effects.
